Using Pharma2000 to engineer Protein-derived Therapeutics

WELCOME

2000 Pharmaceuticals Ltd is a recently established Australian biotech company based on the identification of a new field for research and commerce.

Mission
The rapid discovery of commercially valuable biological drug candidates and their development in-house and via collaborations.

Platform
2000 Pharmaceuticals has invented a novel drug discovery platform harnessing state-of-the-art automated proteomics and bioassay technologies.

People
2000 Pharmaceuticals's founders have, between them, over 100 years of biotech industry experience including several early-stage ventures of which 3 have listed (Genentech and Sugen in the USA, Bionomics in Australia), well over 100 patents/licenses, and over 1000 publications in leading scientific journals.

Location
The company commenced operations in March 2002 at laboratory facilities located at the Baker Heart Research Institute, Melbourne, Victoria.

Focus
The initial drugs being sought are anti-thrombotics which are essential for management of cardiovascular disease (CVD).